The wide-neck bifurcation aneurysms segment by application is estimated to lead the market growth during the forecast period.

According to a new market research study of “Europe Coil Assisted Flow Diverters Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Application, End User and Country.” The Europe coil assisted flow diverters market is expected to reach US$ 120.47 million in 2028 from US$ 73.87 million in 2021; it is expected to grow at a CAGR of 7.2% from 2021 to 2028.  The report highlights trends prevailing in the Europe coil assisted flow diverters market and the factors driving market along with those that act as hindrances. Key factors that are driving growth of the market are rising incidence of intracranial aneurysms and growing incidence of hypertension, smoking, alcoholism, and obesity fuel the growth of the market. However, high cost of neurosurgical devices is expected to restrict the market growth during the forecast period.

Coil assisted flow diverters are stent-like devices that are used to for the embolization of intracranial aneurysms. Thus, increasing incidence of intracranial aneurysms is propelling the demand for coil assisted flow diverters. As per the NHS, in 2019, every year in UK, 1 in 12,500 people have a ruptured brain aneurysm in England. Additionally, as per the ‘Unruptured Intracranial Aneurysms—Pathogenesis and Individualized Management’ report published in 2020, published in Deutsches Ärzteblatt International, stated around 2 million people (adults) in Germany have an unruptured intracranial aneurysm (IA). Thus, increasing prevalence of intracranial aneurysms is creating high demand for coil assisted flow diverters. Also, hypertension, smoking, alcoholism, and obesity are associated with the development of brain aneurysms. Thus, increasing prevalence of these diseases is likely to fuel the demand for coil assisted flow diverters. In addition to this, the growing geriatric population, the rise in associated neurological disorders and technological advancements in coil assisted flow diverters across Europe are likely to create growth opportunities for the market.

Countries in the European regions were profoundly affected due to the COVID-19 pandemic. Due to the second wave of COVID-19 cases, many countries' government is working towards boosting up their cell therapies, gene therapies and regenerative medicines produced by various companies. Increasing COVID-19 has affected the diagnosis and treatment of diseases, due to the diversification of the medical workforce and decision to focus on treating the critically ill. Due to the current pandemic, many research organizations in Europe, are focusing more on COVID 19 studies and are working hard to better understand the virus. The European Academy of Neurology (EAN) has launched a survey on neurological symptoms in COVID-19 patients in order to better understand the neurological manifestations of COVID-19 disease. Thus, the growing focus on corona-virus, is likely to have negative effect on the market.

The Europe coil assisted flow diverters market, by application, is segmented into wide-neck bifurcation aneurysms, and narrow bifurcation aneurysms. Based on end user, the Europe coil assisted flow diverters market is segmented into hospitals, clinics, and ambulatory surgical centers. Geographically, the Europe coil assisted flow diverters market can be segmented into UK, Germany, France, Italy, Spain and Rest of Europe.

Balt USA LLC, MicroPort Scientific Corporation, Stryker Corporation, Penumbra, Inc, Medtronic, Acandis GmbH, MicroVention Inc, Johnson and Johnson Services, Inc., Lepu Medical Technology Co. Ltd., and Cerus Endovascular are among the leading companies operating in the Europe coil assisted flow diverters market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com